查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566762

骨移植和替代品市场：按类型、应用和最终用户分类：2024-2033 年全球机会分析和产业预测

Bone Grafts and Substitutes Market By Type , By Application By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年骨移植和替代品市场价值为 28 亿美元，预计 2024 年至 2033 年复合年增长率为 4.4%，到 2033 年达到 44 亿美元。

骨移植和替代物是用于在各种医疗手术中替代缺失或损坏的骨骼的装置。它在整形外科和脊椎外科中发挥着重要作用。骨移植和替代物的主要目的是透过为新骨生长提供支架并增强骨组织修復和再生来支持身体的自然癒合过程。因此，骨移植物和替代物成为现代医学的重要工具，可显着改善各外科领域的病患预后。

全球骨移植和替代品市场的成长主要是由整形外科疾病发病率的惊人增加、骨折和运动伤害病例的增加所推动的。根据荷兰资讯服务公司 Wolters Kluwer 发表的一项研究，全球每年进行约 200 万例骨移植手术。其中，仅在美国每年就进行 50 万例骨移植手术。此外，老年人口的快速增加也对市场成长做出了重大贡献。老年人更容易患骨质疏鬆症和关节炎等骨骼相关疾病。这是因为老年人骨骼中的矿物质开始被滤出，使骨骼变得脆弱且容易断裂，这就是为什么需要骨头采集器。根据世界卫生组织（WHO）的数据，2019年60岁以上的人口有10亿人。预计到 2030 年，这一数字将增至 14 亿，到 2050 年将增至 21 亿。此外，人们对微创手术技术（通常使用骨移植和替代品）的偏好转变，对市场成长做出了重大贡献。此外，医疗保健支出的增加，特别是在新兴市场，正在改善先进整形外科治疗的机会，包括骨移植手术，这是全球市场的主要驱动力。然而，与骨头移植术相关的高成本和免疫排斥风险是全球市场的主要阻碍因素。相反，移植材料和手术技术的技术创新，例如生物活性骨移植物和合成骨移植物的开拓，正在扩大骨移植手术的应用并改善骨移植手术的结果，并且预计在预测期内将会增加。预计将为市场成长开闢新途径。例如，生物活性材料（例如生物活性玻璃和陶瓷）由于具有促进骨再生的能力而越来越受欢迎。此外，2020年，美国食品药物管理局核准了一种新型合成移植骨替代物，旨在促进整形外科和脊椎手术中的骨癒合，这标誌着市场的持续进步反映了监管支持。

全球骨移植和替代品市场按类型、应用、最终用户和地区细分。依类型分为同种异体移植物、替代移植物和细胞基质。依用途分为脊椎融合、创伤、颅颚颜面手术、关节重组、牙科植骨等。依最终使用者分为医院、专科诊所等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，骨移植替代品细分市场在 2023 年占据最大份额。

从应用来看，脊椎融合部分在 2023 年占据最大的骨移植和替代品市场规模，预计到 2033 年将保持其主导地位。

以最终用户计算，到 2023 年，医院部门将成为主要股东。

按地区划分，北美预计将在 2023 年获得市场占有率，而这一趋势预计将在预测期内持续下去。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 国家、区域和全球各级的患者/流行病学资料
  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章骨移植和替代品市场：按类型

  • 市场概况
  • 同种异体移植物
    • 机械加工移植物
    • 去矿骨基质
  • 替代骨移植
    • 骨形成蛋白（BMP）
    • 合成骨移植物
  • 基于细胞的矩阵

第五章骨移植与替代品市场：依应用分类

  • 市场概况
  • 脊椎融合
  • 创伤
  • 关节重组
  • 牙科骨移植
  • 颅颚颜面

第六章骨移植和替代品市场：依最终用户分类

  • 市场概况
  • 医院
  • 专科诊所
  • 其他的

第七章骨移植和替代品市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国骨移植和替代品市场
    • 加拿大骨移植和替代品市场
    • 墨西哥骨移植和替代品市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国骨移植与替代品市场
    • 德国骨移植与替代品市场
    • 义大利骨移植和替代品市场
    • 西班牙骨移植和替代品市场
    • 英国骨移植与替代品市场
    • 其他欧洲骨移植和替代品市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国骨移植及替代品市场
    • 日本骨移植及替代品市场
    • 印度骨移植和替代品市场
    • 韩国骨移植和替代品市场
    • 澳洲骨移植和替代品市场
    • 其他亚太地区骨移植和替代品市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西骨移植与替代品市场
    • 南非骨移植和替代品市场
    • 沙乌地阿拉伯骨移植物和替代品市场
    • 其他拉丁美洲/中东/非洲骨移植和替代市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Arthrex, Inc
  • Johnson And Johnson
  • Medtronic Plc
  • NuVasive, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Baxter International Inc.
  • Xtant Medical Holdings, Inc.
  • Integra LifeSciences
  • Orthofix Holdings, Inc.
简介目录
Product Code: A01446

The bone grafts and substitutes market was valued at $2.8 billion in 2023, and is projected to reach $4.4 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

Bone grafts and substitutes are devices that are used to replace missing or damaged bone in various medical procedures. They play a crucial role in orthopedics and spinal surgeries. The primary purpose of bone grafts and substitutes is to support the body's natural healing process by providing a scaffold for new bone growth, enhancing the repair and regeneration of bone tissue. Thus, bone grafts and substitutes serve as vital tools in modern medicine, significantly improving patient outcomes in various surgical disciplines.

The growth of the global bone grafts and substitutes market is majorly driven by alarming increase in incidence of orthopedic conditions and rise in cases of fractures and sports injuries. A study published by Wolters Kluwer, a Dutch information services company, stated that approximately two million bone grafting procedures are performed worldwide per year. Among these, 500,000 bone graft are performed annually in the U.S. alone. Moreover, surge in geriatric population significantly contributes toward the market growth. Aged individuals are highly susceptible to bone-related disorders such as osteoporosis and arthritis. This is attributed to the fact that minerals in bones of aged individuals start to leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone harvesters. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, shift in preference toward minimally invasive surgical techniques, which often involve bone grafts and substitutes, is notably contributing to the market growth. In addition, increase in healthcare expenditure, especially in developing regions, is improving the access to advanced orthopedic treatments, including bone grafting procedures, which acts as a significant driving force of the global market. However, high cost associated with bone grafting procedures and risk of immune rejection act as the key deterrent factors of the global market. On the contrary, innovations in graft materials and surgical techniques, such as the development of bioactive and synthetic bone grafts, have expanded the applications and improved the outcomes of bone grafting procedures, which are expected to open new avenues for the growth of the market during the forecast period. For instance, bioactive materials, such as bioactive glass and ceramics, are gaining traction due to their ability to enhance bone regeneration. Moreover, in 2020, the U.S. Food and Drug Administration approved a novel synthetic bone graft substitute designed to enhance bone healing in orthopedic and spinal surgeries, reflecting ongoing advancements and regulatory support in the market.

The global bone grafts and substitutes market analysis is segmented into type, application, end user, and region. On the basis of type, the market is categorized into allografts, bone grafts substitute, and cell-based matrices. Depending on application, it is divided into spinal fusion, trauma, craniomaxillofacial surgery, joint reconstruction, and dental bone grafting. By end user, it is classified into hospitals, specialty clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the bone grafts substitute segment accounted for the largest share in 2023.

Depending on application, the spinal fusion segment occupied largest bone grafts and substitutes market size in 2023, and is expected to remain dominant by 2033.

By end user, the hospitals segment was the major shareholder in 2023.

Region wise, North America garnered market share in 2023, and is anticipated to continue this trend during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bone grafts and substitutes market include Arthrex, Inc, Johnson & Johnson, Medtronic plc, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Baxter International Inc., Xtant Medical Holdings, Inc., Integra LifeSciences, and Orthofix Holdings, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Allografts
    • Machined allografts
    • Demineralized bone matrix
  • Bone grafts substitutes
    • Bone morphogenic proteins (BMP)
    • Synthetic bone grafts
  • Cell based matrices

By Application

  • Spinal fusion
  • Trauma
  • Joint reconstruction
  • Dental bone grafting
  • Craniomaxillofacial

By End User

  • Hospitals
  • Specialty clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Arthrex, Inc
    • Johnson & Johnson
    • Medtronic plc
    • NuVasive, Inc.
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Baxter International Inc.
    • Xtant Medical Holdings, Inc.
    • Integra LifeSciences
    • Orthofix Holdings, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Allografts
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.5. Machined allografts
      • 4.2.5.1. Market Size and Forecast
    • 4.2.6. Demineralized bone matrix
      • 4.2.6.1. Market Size and Forecast
  • 4.3. Bone Grafts Substitutes
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
    • 4.3.5. Bone morphogenic proteins (BMP)
      • 4.3.5.1. Market Size and Forecast
    • 4.3.6. Synthetic bone grafts
      • 4.3.6.1. Market Size and Forecast
  • 4.4. Cell Based Matrices
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Spinal Fusion
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Trauma
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Joint Reconstruction
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Dental Bone Grafting
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Craniomaxillofacial
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Bone Grafts and Substitutes Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Bone Grafts and Substitutes Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Bone Grafts and Substitutes Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Bone Grafts and Substitutes Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Bone Grafts and Substitutes Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Bone Grafts and Substitutes Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Bone Grafts and Substitutes Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Bone Grafts and Substitutes Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Bone Grafts and Substitutes Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Bone Grafts and Substitutes Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Bone Grafts and Substitutes Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Bone Grafts and Substitutes Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Bone Grafts and Substitutes Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Bone Grafts and Substitutes Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Bone Grafts and Substitutes Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Bone Grafts and Substitutes Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Bone Grafts and Substitutes Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Bone Grafts and Substitutes Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Bone Grafts and Substitutes Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Arthrex, Inc
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Johnson And Johnson
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Medtronic Plc
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. NuVasive, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Stryker Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Zimmer Biomet Holdings, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Baxter International Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Xtant Medical Holdings, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Integra LifeSciences
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Orthofix Holdings, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments